Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Immupharma updates on successful placing

Drug discovery firm ImmuPharma has raised £7.7mln from the previously announced fundraise and is due to receive a further £0.7mln from advance assurances.
Immupharma updates on successful placing
It has applied to HMRC to receive VCT Advance Assurance and / or EIS Advance Assurances to raise the further £0.7mln but these must be obtained no later than March 23..

Drug discovery firm ImmuPharma (LON:IMM) has  raised £7.7mln from the previously announced fundraise and is due to receive a further £0.7mln from advance assurances.

It has applied to HMRC to receive VCT Advance Assurance and / or EIS Advance Assurances to raise the further £0.7mln but these must be obtained no later than March 23.

The firm has said the cash will be used to fund its share of the costs of developing Lupuzor, its potential blockbuster drug for the autoimmune disease Lupus, which is currently undergoing phase III clinical trials and also provide the firm with its working capital requirements through to 2018.

Immupharma shares eased 2.08% to 23.5p.

Giles_55af4ddca6481.jpg
Why Invest In ImmuPharma PLC? Read More Here

Register here to be notified of future IMM Company articles
View full IMM profile

ImmuPharma PLC Timeline

Related Articles

stem-cells.jpg
February 25 2016
Early 2016 looks to be data-rich for stem cell group ReNeuron as it progresses its clinical portfolio on multiple fronts.
immupharma-_kiss_pic_with_mum.png
March 01 2016
Lupuzor is not the only part of the Immupharma story and McCarthy plans also to raise the profile of the rest of the group's early stage pipeline in 2016.....
A graphic of a tumour growing in the body
July 07 2016
Nanobiotix is a late clinical-stage nanomedicine company researching novel approaches to enhance radiotherapy for the local treatment of cancer.

© Proactive Investors 2016

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.